MANAGEMENT OF BIOSIMILARS: KEY CONSIDERATIONS FOR PHARMACISTS IN PATIENT CARE

被引：0
|
作者：
Mohite, N. [1 ]
Nayak, R. [1 ]
机构：
[1] St Johns Univ, Queens, NY USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.610
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP19
引用
收藏
页码：S90 / S90
页数：1
相关论文
共 50 条
  • [1] Biosimilars: Practical Considerations for Pharmacists
    Stevenson, James G.
    Popovian, Robert
    Jacobs, Ira
    Hurst, Susan
    Shane, Lesley G.
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (07) : 590 - 602
  • [2] Current and Future Directions in MS Management: Key Considerations for Managed Care Pharmacists
    Lipsy, Robert J.
    Schapiro, Randall T.
    Prostko, Chris R.
    JOURNAL OF MANAGED CARE PHARMACY, 2009, 15 (09): : S2 - S15
  • [3] Key Considerations in Biosimilars Development
    Donninger, Raymond
    Bower, Joe
    Kaiser, Raymond
    Estdale, Sian
    Carlsen, John
    BIOPHARM INTERNATIONAL, 2012, 25 (10) : 37 - 39
  • [4] Biosimilars in the Caribbean - Key Considerations
    Cox, S. Dawkins
    WEST INDIAN MEDICAL JOURNAL, 2012, 61 (09): : 849 - 852
  • [5] Key considerations in the preclinical development of biosimilars
    Bui, Lynne A.
    Hurst, Susan
    Finch, Gregory L.
    Ingram, Beverly
    Jacobs, Ira A.
    Kirchhoff, Carol F.
    Ng, Chee-Keng
    Ryan, Anne M.
    DRUG DISCOVERY TODAY, 2015, 20 : 3 - 15
  • [6] Comprehensive care is key in HIV management, pharmacists say
    Traynor, Kate
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2016, 73 (17) : 1290 - 1291
  • [7] Biosimilars and patient care
    Mossner, Rotraut
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 (02): : 133 - 134
  • [8] Clinical documentation for patient care: Models, concepts, and liability considerations for pharmacists
    Zierler-Brown, Seena
    Brown, Timothy R.
    Chen, David
    Blackburn, Robert Wayne
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2007, 64 (17) : 1851 - 1858
  • [9] BIOSIMILARS ENTRY TO ONCOLOGY PRACTICE: KEY NURSING CONSIDERATIONS
    Zack, Eric
    ONCOLOGY NURSING FORUM, 2019, 46 (02)
  • [10] Biosimilars: Key regulatory considerations and similarity assessment tools
    Kirchhoff, Carol F.
    Wang, Xiao-Zhuo Michelle
    Conlon, Hugh D.
    Anderson, Scott
    Ryan, Anne M.
    Bose, Arindam
    BIOTECHNOLOGY AND BIOENGINEERING, 2017, 114 (12) : 2696 - 2705
12345